A German pharmaceutical company has developed a way to produce cannabinoids in bacteria, and its ambitions are anything but microscopic.
Analytical Cannabis catches up on a momentous month for the UK cannabis field.
A new peer-reviewed study found that many customers at Colorado’s dispensaries use cannabis to ease issues like pain and insomnia.
Recently published research examines links between CBD doses and the potential for developing “hepatotoxicity” — drug-induced liver damage.
Canadian citizens and industry stakeholders are being invited by Health Canada to take part in a new consultation launched by the healthcare regulator last week.
The US House of Representatives has voted to approve a far-reaching amendment which would block the Department of Justice from interfering with state-legal cannabis laws.
Bacteria could soon be joining the CBD boom, according to new research which claims that the cannabinoid could be a major antibiotic candidate.
Cannabis edibles will soon be available in Canada, but they'll now have to abide by some confusing rules that may prohibit cannabis cookies and gummies.